NXS 2.27% 22.5¢ next science limited

Ann: XPERIENCE study findings published, page-3

  1. 221 Posts.
    lightbulb Created with Sketch. 122
    The evidence keeps on building! It's just crazy that this is not bigger news.

    To be honest, the big drug companies would probably like to squash this novel technology as it reduces the need for their products.

    One of them has to wake up to its potential at some point. When NXS builds up enough irrefutable evidence, I would expect a giant offer from one of the big pharma companies.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $66.36M
Open High Low Value Volume
22.0¢ 22.8¢ 22.0¢ $5.015K 22.42K

Buyers (Bids)

No. Vol. Price($)
2 231 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 15975 2
View Market Depth
Last trade - 14.59pm 02/07/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.